Published on in Vol 4 , No 9 (2020) :September

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/17126, first published .
Lifestyle Interventions for Polycystic Ovary Syndrome: Cross-Sectional Survey to Assess Women's Treatment and Outcome Preferences

Lifestyle Interventions for Polycystic Ovary Syndrome: Cross-Sectional Survey to Assess Women's Treatment and Outcome Preferences

Lifestyle Interventions for Polycystic Ovary Syndrome: Cross-Sectional Survey to Assess Women's Treatment and Outcome Preferences

Authors of this article:

Laura R Saslow 1 Author Orcid Image ;   James E Aikens 2 Author Orcid Image

Journals

  1. Cignarella A, Mioni R, Sabbadin C, Dassie F, Parolin M, Vettor R, Barbot M, Scaroni C. Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS. International Journal of Molecular Sciences 2020;21(24):9554 View
  2. Liu Z, Song Y, Xu Y, Wang J, Hu H, Weng Y. The comparison of the effectiveness and safety of drospirone ethinyl estradiol and ethinyl estradiol cyproterone in the treatment of polycystic ovarian syndrome. Medicine 2020;99(51):e23811 View
  3. Choi H, Lee S, Yang S. Development of an integrated mobile application for lifestyle modification in women with polycystic ovarian syndrome. Journal of Clinical Nursing 2023;32(1-2):49 View
  4. H. Al Wattar B, M. Hussain N, S. Khan K. Lifestyle interventions in women with polycystic ovary syndrome: A scoping systematic review of randomised evidence. Medicina de Familia. SEMERGEN 2022;48(3):186 View